Lundtorp-Olsen Christine, Markvart Merete, Twetman Svante, Belstrøm Daniel
Department of Odontology, Section for Clinical Oral Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Pathogens. 2024 May 16;13(5):419. doi: 10.3390/pathogens13050419.
Data from systematic reviews and meta-analyses show that probiotics positively impact clinical parameters of oral diseases such as gingivitis, dental caries, and periodontitis. However, the working mechanism of probiotics is not fully understood, but is hypothesized to be mediated by direct and indirect interactions with the oral microbiota and the human host. In the present narrative review, we focused on the microbiological effect of probiotic supplements based on data retrieved from randomized clinical trials (RCTs). In addition, we assessed to what extent contemporary molecular methods have been employed in clinical trials in the field of oral probiotics. Multiple RCTs have been performed studying the potential effect of probiotics on gingivitis, dental caries, and periodontitis, as evaluated by microbial endpoints. In general, results are conflicting, with some studies reporting a positive effect, whereas others are not able to record any effect. Major differences in terms of study designs and sample size, as well as delivery route, frequency, and duration of probiotic consumption, hamper comparison across studies. In addition, most RCTs have been performed with a limited sample size using relatively simple methods for microbial identification, such as culturing, qPCR, and DNA-DNA checkerboard, while high-throughput methods such as 16S sequencing have only been employed in a few studies. Currently, state-of-the-art molecular methods such as metagenomics, metatranscriptomics, and metaproteomics have not yet been used in RCTs in the field of probiotics. The present narrative review revealed that the effect of probiotic supplements on the oral microbiota remains largely uncovered. One important reason is that most RCTs are performed without studying the microbiological effect. To facilitate future systematic reviews and meta-analyses, an internationally agreed core outcome set for the reporting of microbial endpoints in clinical trials would be desirable. Such a standardized collection of outcomes would most likely improve the quality of probiotic research in the oral context.
系统评价和荟萃分析的数据表明,益生菌对牙龈炎、龋齿和牙周炎等口腔疾病的临床参数有积极影响。然而,益生菌的作用机制尚未完全明确,但据推测是通过与口腔微生物群和人类宿主的直接和间接相互作用介导的。在本叙述性综述中,我们基于从随机临床试验(RCT)中检索到的数据,重点关注益生菌补充剂的微生物学效应。此外,我们评估了当代分子方法在口腔益生菌领域的临床试验中的应用程度。多项RCT研究了益生菌对牙龈炎、龋齿和牙周炎的潜在影响,并通过微生物终点进行评估。总体而言,结果相互矛盾,一些研究报告了积极效果,而另一些研究则未发现任何效果。研究设计、样本量以及益生菌摄入的给药途径、频率和持续时间等方面的重大差异,妨碍了不同研究之间的比较。此外,大多数RCT的样本量有限,使用相对简单的微生物鉴定方法,如培养、定量PCR和DNA-DNA杂交棋盘法,而高通量方法如16S测序仅在少数研究中使用。目前,宏基因组学、宏转录组学和宏蛋白质组学等先进的分子方法尚未用于益生菌领域的RCT。本叙述性综述表明,益生菌补充剂对口腔微生物群的影响在很大程度上仍未得到揭示。一个重要原因是,大多数RCT在进行时没有研究微生物学效应。为了便于未来的系统评价和荟萃分析,制定一个国际认可的临床试验中微生物终点报告的核心结局集将是可取的。这样一个标准化的结局集很可能会提高口腔领域益生菌研究的质量。